IL6 and neurodegenerative disease: The modulation of IL-6 signaling pathways, coupled with leveraging the immunomodulatory prowess of MSCs, emerges as a compelling avenue for developing therapeutic strategies aimed at alleviating neuroinflammation and fostering neurological recovery in neurodegenerative diseases and neurological injuries.